Skip to main content

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.

An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy

National Cancer Institute "Cancer Moonshot Biobank"

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about National Cancer Institute "Cancer Moonshot Biobank"

A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease

Evaluation of Health Costs and Resource Utilization

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Evaluation of Health Costs and Resource Utilization

Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism

A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI

Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 18:36
  • Read more about Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 47
  • Page 48
  • Page 49
  • Page 50
  • Page 51
  • Page 52
  • Page 53
  • Page 54
  • Page 55
  • …
  • Next page Next
  • Last page Last
Subscribe to